相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Skin-specific antibodies neutralizing mycolactone toxin during the spontaneous healing of Mycobacterium ulcerans infection
Melanie Foulon et al.
SCIENCE ADVANCES (2020)
Does skin surface temperature variation account for Buruli ulcer lesion distribution?
Nicola K. Sexton-Oates et al.
PLOS NEGLECTED TROPICAL DISEASES (2020)
Buruli ulcer: The Efficacy of Innate Immune Defense May Be a Key Determinant for the Outcome of Infection With Mycobacterium ulcerans
Katharina Roltgen et al.
FRONTIERS IN MICROBIOLOGY (2020)
Buruli ulcer: cured by 8 weeks of oral antibiotics?
Paul D. R. Johnson
LANCET (2020)
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial
Richard O. Phillips et al.
LANCET (2020)
Structure of the Inhibited State of the Sec Translocon
Samuel F. Gerard et al.
MOLECULAR CELL (2020)
Introduction of Mycobacterium ulcerans disease in the Bankim Health District of Cameroon follows damming of the Mape River
Koen Vandelannoote et al.
PLOS NEGLECTED TROPICAL DISEASES (2020)
Spatiotemporal analysis of mycolactone distribution in vivo reveals partial diffusion in the central nervous system
Emma Colucci-Guyon et al.
PLOS NEGLECTED TROPICAL DISEASES (2020)
Natural products as modulators of eukaryotic protein secretion
Hendrik Luesch et al.
NATURAL PRODUCT REPORTS (2020)
Understanding the Significance of Biochemistry in the Storage, Handling, Purification, and Sampling of Amphiphilic Mycolactone
Jessica Z. Kubicek-Sutherland et al.
TOXINS (2019)
Recombinant Antibodies against Mycolactone
Leslie Naranjo et al.
TOXINS (2019)
Mapping the global distribution of Buruli ulcer: a systematic review with evidence consensus
Hope Simpson et al.
LANCET GLOBAL HEALTH (2019)
Paradoxical reactions in Buruli ulcer after initiation of antibiotic therapy: Relationship to bacterial load
Michael Frimpong et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Blocking Protein Secretion with Novel Small Molecule Inhibitors of Sec61 Represents a Potential Treatment Strategy Against Hematologic Malignancies
Eric Lowe et al.
BLOOD (2019)
Global Epidemiology of Buruli Ulcer, 2010-2017, and Analysis of 2014 WHO Programmatic Targets
Till F. Omansen et al.
EMERGING INFECTIOUS DISEASES (2019)
Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease
Jeannette Guarner
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Proteomics Reveals Scope of Mycolactone-mediated Sec61 Blockade and Distinctive Stress Signature
Jean-David Morel et al.
MOLECULAR & CELLULAR PROTEOMICS (2018)
Correlates of immune exacerbations in leprosy
Annemieke Geluk
SEMINARS IN IMMUNOLOGY (2018)
Inhibition of Sec61-dependent translocation by mycolactone uncouples the integrated stress response from ER stress, driving cytotoxicity via translational activation of ATF4
Joy Ogbechi et al.
CELL DEATH & DISEASE (2018)
Membrane perturbing properties of toxin mycolactone from Mycobacterium ulcerans
Cesar A. Lopez et al.
PLOS COMPUTATIONAL BIOLOGY (2018)
The potent effect of mycolactone on lipid membranes
Milene Nitenberg et al.
PLOS PATHOGENS (2018)
Sec61 blockade by mycolactone: A central mechanism in Buruli ulcer disease
Caroline Demangel et al.
BIOLOGY OF THE CELL (2018)
Buruli Ulcer: a Review of the Current Knowledge
Rie R. Yotsu et al.
CURRENT TROPICAL MEDICINE REPORTS (2018)
Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans
Dezemon Zingue et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Mycolactone reveals the substrate-driven complexity of Sec61-dependent transmembrane protein biogenesis
Michael McKenna et al.
JOURNAL OF CELL SCIENCE (2017)
Sec61 blockade by mycolactone inhibits antigen cross-presentation independently of endosome-to-cytosol export
Jeff E. Grotzke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Infiltrating leukocytes surround early Buruli ulcer lesions, but are unable to reach the mycolactone producing mycobacteria
Marie-Therese Ruf et al.
VIRULENCE (2017)
Mycobacterium ulcerans low infectious dose and mechanical transmission support insect bites and puncturing injuries in the spread of Buruli ulcer
John R. Wallace et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Susceptibility to Mycobacterium ulcerans Disease (Buruli ulcer) Is Associated with IFNG and iNOS Gene Polymorphisms
Stephanie Bibert et al.
FRONTIERS IN MICROBIOLOGY (2017)
Total Syntheses of Mycolactone A/B and its Analogues for the Exploration of the Biology of Buruli Ulcer
Sarah Saint-Auret et al.
CHIMIA (2017)
The chemistry and biology of mycolactones
Matthias Gehringer et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2017)
Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells
Blandine Monel et al.
EMBO JOURNAL (2017)
Exposure Risk for Infection and Lack of Human-to-Human Transmission of Mycobacterium ulcerans Disease, Australia
Daniel P. O'Brien et al.
EMERGING INFECTIOUS DISEASES (2017)
Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease
Fred Stephen Sarfo et al.
CELLULAR MICROBIOLOGY (2016)
Mechanistic insights into the inhibition of Sec61-dependent co- and post-translational translocation by mycolactone
Michael McKenna et al.
JOURNAL OF CELL SCIENCE (2016)
Mycolactone subverts immunity by selectively blocking the Sec61 translocon
Ludivine Baron et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
FVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer
Estelle Marion et al.
JOURNAL OF IMMUNOLOGY (2016)
Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice
Raphael Bieri et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Antibody-Mediated Neutralization of the Exotoxin Mycolactone, the Main Virulence Factor Produced by Mycobacterium ulcerans
Jean-Pierre Dangy et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Genetic Susceptibility and Predictors of Paradoxical Reactions in Buruli Ulcer
Yves Thierry Barogui et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Neutrophil migration in infection and wound repair: going forward in reverse
Sofia de Oliveira et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Short Report: Buruli Ulcer Control in a Highly Endemic District in Ghana: Role of Community-Based Surveillance Volunteers
Kabiru Mohammed Abass et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2015)
Shaping mycolactone for therapeutic use against inflammatory disorders
Laure Guenin-Mace et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Loop-Mediated Isothermal Amplification for Laboratory Confirmation of Buruli Ulcer Disease-Towards a Point-of-Care Test
Marcus Beissner et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease
Fred S. Sarfo et al.
BMC INFECTIOUS DISEASES (2014)
Epidemiology and management of Buruli ulcer
Gene Khai Lin Huang et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2014)
The urgent need for clinical, diagnostic, and operational research for management of Buruli ulcer in Africa
Daniel P. O'Brien et al.
LANCET INFECTIOUS DISEASES (2014)
HIV infection and Buruli ulcer in Africa
Quentin B. Vincent et al.
LANCET INFECTIOUS DISEASES (2014)
Analysis of the Vaccine Potential of Plasmid DNA Encoding Nine Mycolactone Polyketide Synthase Domains in Mycobacterium ulcerans Infected Mice
Virginie Roupie et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
The Pathogenic mechanism of the mycobacterium ulcerans virulence factor, mycolactone, deends on blockade of protein translocation intot he ER
Belinda S. Hall et al.
PLOS PATHOGENS (2014)
Neutrophil-derived cytokines: facts beyond expression
Cristina Tecchio et al.
FRONTIERS IN IMMUNOLOGY (2014)
Impact of Human Immunodeficiency Virus on the Severity of Buruli Ulcer Disease: Results of a Retrospective Study in Cameroon
Vanessa Christinet et al.
OPEN FORUM INFECTIOUS DISEASES (2014)
The Cell Wall-Associated Mycolactone Polyketide Synthases Are Necessary but Not Sufficient for Mycolactone Biosynthesis
Jessica L. Porter et al.
PLOS ONE (2013)
Regulation of Mycolactone, the Mycobacterium ulcerans Toxin, Depends on Nutrient Source
Caroline Deshayes et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Structure-Activity Relationship Studies on the Macrolide Exotoxin Mycolactone of Mycobacterium ulcerans
Nicole Scherr et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer
Kenneth D. Doig et al.
BMC GENOMICS (2012)
Paradoxical Responses After Start of Antimicrobial Treatment in Mycobacterium ulcerans Infection
Willemien A. Nienhuis et al.
CLINICAL INFECTIOUS DISEASES (2012)
Cellular Immunity Confers Transient Protection in Experimental Buruli Ulcer following BCG or Mycolactone-Negative Mycobacterium ulcerans Vaccination
Alexandra G. Fraga et al.
PLOS ONE (2012)
Buruli ulcer
Thorbjorg Einarsdottir et al.
HUMAN VACCINES (2011)
Mycolactone impairs T cell homing by suppressing microRNA control of L-selectin expression
Laure Guenin-Mace et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Chemistry of mycolactones, the causative toxins of Buruli ulcer
Yoshito Kishi
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Mycolactone Diffuses into the Peripheral Blood of Buruli Ulcer Patients - Implications for Diagnosis and Disease Monitoring
Fred S. Sarfo et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Secondary Buruli Ulcer Skin Lesions Emerging Several Months after Completion of Chemotherapy: Paradoxical Reaction or Evidence for Immune Protection?
Marie-Therese Ruf et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
A Genotypic Approach for Detection, Identification, and Characterization of Drug Resistance in Mycobacterium ulcerans in Clinical Samples and Isolates from Ghana
Marcus Beissner et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Risk factors for Mycobacterium ulcerans infection
Kathryn H. Jacobsen et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
Mycolactone Suppresses T Cell Responsiveness by Altering Both Early Signaling and Posttranslational Events
Sheerazed Boulkroun et al.
JOURNAL OF IMMUNOLOGY (2010)
IFN-γ-Dependent Activation of Macrophages during Experimental Infections by Mycobacterium ulcerans Is Impaired by the Toxin Mycolactone
Egidio Torrado et al.
JOURNAL OF IMMUNOLOGY (2010)
Mycobacterium ulcerans and Other Mycolactone-Producing Mycobacteria Should Be Considered a Single Species
Sacha J. Pidot et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
A Major Role for Mammals in the Ecology of Mycobacterium ulcerans
Janet A. M. Fyfe et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Ecology and Transmission of Buruli Ulcer Disease: A Systematic Review
Richard W. Merritt et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Phagocytosis of Mycobacterium ulcerans in the course of rifampicin and streptomycin chemotherapy in Buruli ulcer lesions
D. Schuette et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Mycolactone Inhibits Monocyte Cytokine Production by a Posttranscriptional Mechanism
Rachel E. Simmonds et al.
JOURNAL OF IMMUNOLOGY (2009)
Immunosuppressive Signature of Cutaneous Mycobacterium ulcerans Infection in the Peripheral Blood of Patients with Buruli Ulcer Disease
Richard Phillips et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans
Caroline Demangel et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Mycolactone Gene Expression Is Controlled by Strong SigA-Like Promoters with Utility in Studies of Mycobacterium ulcerans and Buruli Ulcer
Nicholas J. Tobias et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Paradoxical immune-mediated reactions to Mycobacterium ulcerans during antibiotic treatment: a result of treatment success, not failure
Daniel P. O'Brien et al.
MEDICAL JOURNAL OF AUSTRALIA (2009)
Association of HIV infection and Mycobacterium ulcerans disease in Benin
Roch C. Johnson et al.
AIDS (2008)
Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria
Hui Hong et al.
NATURAL PRODUCT REPORTS (2008)
Distribution of Mycobacterium ulcerans in Buruli Ulcer Endemic and Non-Endemic Aquatic Sites in Ghana
Heather R. Williamson et al.
PLOS NEGLECTED TROPICAL DISEASES (2008)
Improved Protective Efficacy of a Species-Specific DNA Vaccine Encoding Mycolyl-Transferase Ag85A from Mycobacterium ulcerans by Homologous Protein Boosting
Audrey Tanghe et al.
PLOS NEGLECTED TROPICAL DISEASES (2008)
Mycolactone Diffuses from Mycobacterium ulcerans-Infected Tissues and Targets Mononuclear Cells in Peripheral Blood and Lymphoid Organs
Hui Hong et al.
PLOS NEGLECTED TROPICAL DISEASES (2008)
Development of Highly Organized Lymphoid Structures in Buruli Ulcer Lesions after Treatment with Rifampicin and Streptomycin
Daniela Schuette et al.
PLOS NEGLECTED TROPICAL DISEASES (2007)
Survival of Mycobacterium ulcerans at 37°C
M. Eddyani et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Total synthesis of mycolactones A and B
Fengbin Song et al.
TETRAHEDRON (2007)
Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone
Emmanuelle Coutanceau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
A booster vaccination with Mycobacterium bovis BCG does not increase the protective effect of the vaccine against experimental Mycobacterium ulcerans infection in mice
Audrey Tanghe et al.
INFECTION AND IMMUNITY (2007)
Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis
Laurent Marsollier et al.
PLOS PATHOGENS (2007)
Evolution of Mycobacterium ulcerans and other mycolactone-producing mycobacteria from a common Mycobacterium marinum progenitor
Marcus J. Yip et al.
JOURNAL OF BACTERIOLOGY (2007)
Evidence for an intramacrophage growth phase of Mycobacterium ulcerans
Egidio Torrado et al.
INFECTION AND IMMUNITY (2007)
Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer
Timothy P. Stinear et al.
GENOME RESEARCH (2007)
Immunogenicity of Mycobacterium ulcerans Hsp65 and protective efficacy of a Mycobacterium leprae Hsp65-based DNA vaccine against Buruli ulcer
Emmanuelle Coutanceau et al.
MICROBES AND INFECTION (2006)
Systemic suppression of interferon-γ responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans
Dorothy Yeboah-Manu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice
MS Oliveira et al.
INFECTION AND IMMUNITY (2005)
Sensitivity of PCR targeting the IS2404 insertion sequence of Mycobacterium ulcerans in an assay using punch biopsy specimens for diagnosis of buruli ulcer
R Phillips et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans:: the contribution of endogenous mycolactone toxin
E Coutanceau et al.
CELLULAR MICROBIOLOGY (2005)
Colonization of the salivary glands of Naucoris cimicoides by Mycobacterium ulcerans requires host plasmatocytes and a macrolide toxin, mycolactone
L Marsollier et al.
CELLULAR MICROBIOLOGY (2005)
Cytokine responses to stimulation of whole blood from patients with buruli ulcer disease in Ghana
BD Westenbrink et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2005)
Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans
TP Stinear et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Differential production of systemic and intralesional gamma interferon and interleukin-10 in nodular and ulcerative forms of Buruli disease
G Prévot et al.
INFECTION AND IMMUNITY (2004)
Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease
F Portaels et al.
INFECTION AND IMMUNITY (2004)
Aquatic snails, passive hosts of Mycobacterium ulcerans
L Marsollier et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2004)
Subtractive hybridization reveals a type I polyketide synthase locus specific to Mycobacterium ulcerans
GA Jenkin et al.
JOURNAL OF BACTERIOLOGY (2003)
Uptake and cellular actions of mycolactone, a virulence determinant for Mycobacterium ulcerans
DS Snyder et al.
MICROBIAL PATHOGENESIS (2003)
Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans:: Implications for virulence
A Mve-Obiang et al.
INFECTION AND IMMUNITY (2003)
Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer
A Tanghe et al.
INFECTION AND IMMUNITY (2001)
Immune response to infection with Mycobacterium ulcerans
TM Gooding et al.
INFECTION AND IMMUNITY (2001)
分享论文
